Literature DB >> 27935122

Outcome and cervical metastatic spread of squamous cell cancer of the buccal mucosa, a retrospective analysis of the past 25 years.

Keyvan Sagheb1, Sebastian Blatt1, Ina Sophie Kraft1, Stefanie Zimmer2, Roman-Kia Rahimi-Nedjat1, Bilal Al-Nawas1, Christian Walter1.   

Abstract

OBJECTIVES: Because of the low proportion of squamous cell carcinomas (SCCs) of the buccal mucosa within the carcinomas of the oral cavity in the Western population, data concerning metastatic pattern are sparse. Therefore, this retrospective study is focusing on the occurrence of cervical metastases (CM) and the overall outcome of this tumor entity.
MATERIALS AND METHODS: From January 1988 to October 2013, 113 patients were treated in the Department of Oral and Maxillofacial Surgery, Mainz, for an oral SCC of the cheek. Metastatic pattern and clinical parameters that are possibly associated with an increased risk for CM as well as overall outcome were analyzed.
RESULTS: The average follow-up was 48 months (range: 1-248 months). A total of 55 (49%) patients were female and 58 (51%) male, with an average age of 65 ± 13 years (♀68 ± 14 years; ♂63 ± 11 years). In total, 55% of the patients either smoked and/or consumed alcohol. In total, 34% of the patients had a stage III or IV tumor, with overall 23% having CM at the time of diagnosis. During the follow-up, 50% (n = 56) of the patients developed a relapse after 12 months (median). Tumor size (P = 0.002*) and grading (P < 0.001*) are significantly associated with the occurrence of CM. Metastases (P = 0.008*) and advanced tumor size (P = 0.018) had an influence on the survival, whereas the relapse had no significant influence (P = 0.928). Five-year survival rate was 80%.
CONCLUSIONS: SCC of the buccal mucosa shows aggressive behavior with a considerably high proportion of relapse. Since overall outcome is significantly decreased by the cervical metastatic pattern, a selective, ipsilateral neck dissection for this patient group is recommended as the primary management.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  head and neck cancer; lymphatic metastasis; oral cancer; squamous cell carcinoma of the buccal mucosa

Mesh:

Year:  2017        PMID: 27935122     DOI: 10.1111/jop.12537

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  5 in total

1.  Do we need a different staging system for tongue and gingivobuccal complex squamous cell cancers?

Authors:  Piyush Gupta; Jocelyn C Migliacci; Pablo H Montero; Daniella Karassawa Zanoni; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Oral Oncol       Date:  2018-02-20       Impact factor: 5.337

2.  Predictive Value of Pin1 in Cervical Low-Grade Squamous Intraepithelial Lesions and Inhibition of Pin1 Exerts Potent Anticancer Activity against Human Cervical Cancer.

Authors:  Yan-Tong Guo; Yan Lu; Yi-Yang Jia; Hui-Nan Qu; Da Qi; Xin-Qi Wang; Pei-Ye Song; Xiang-Shu Jin; Wen-Hong Xu; Yuan Dong; Ying-Ying Liang; Cheng-Shi Quan
Journal:  Aging Dis       Date:  2020-02-01       Impact factor: 6.745

3.  Elective neck dissection versus wait-and-see policy in cT1N0 buccal squamous cell carcinoma.

Authors:  Qigen Fang; Hua Gao; Qing Gao; Jinlan Sun; Peng Li; Meng Cui; Enxi Zhang; Wenlong Yin; Yuanyuan Dong
Journal:  BMC Cancer       Date:  2020-06-09       Impact factor: 4.430

4.  Impact of submandibular gland preservation in neck management of early-stage buccal squamous cell carcinoma on locoregional control and disease-specific survival.

Authors:  Bo Gu; Qigen Fang; Yao Wu; Wei Du; Xu Zhang; Defeng Chen
Journal:  BMC Cancer       Date:  2020-10-27       Impact factor: 4.430

5.  Clinicopathological Characteristics and Survival Outcomes of Patients with Buccal Squamous Cell Carcinoma: Results of a Multi-Institutional Study.

Authors:  Shogo Shinohara; Masahiro Kikuchi; Hiroyuki Harada; Kiyomi Hamaguchi; Ryo Asato; Hisanobu Tamaki; Masanobu Mizuta; Ryusuke Hori; Tsuyoshi Kojima; Keigo Honda; Takashi Tsujimura; Yohei Kumabe; Kazuyuki Ichimaru; Yoshiharu Kitani; Koji Ushiro; Koichi Omori
Journal:  Medicina (Kaunas)       Date:  2021-12-13       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.